Your browser doesn't support javascript.
loading
Rutin as A Novel c-Met Inhibitory Lead for The Control of Triple Negative Breast Malignancies.
Elsayed, Heba E; Ebrahim, Hassan Y; Mohyeldin, Mohamed M; Siddique, Abu Bakar; Kamal, Amel M; Haggag, Eman G; El Sayed, Khalid A.
Afiliación
  • Elsayed HE; a Department of Basic Pharmaceutical Sciences, School of Pharmacy , University of Louisiana at Monroe , Monroe , Louisiana.
  • Ebrahim HY; b Department of Pharmacognosy, Faculty of Pharmacy , Helwan University , Helwan , Cairo , Egypt.
  • Mohyeldin MM; a Department of Basic Pharmaceutical Sciences, School of Pharmacy , University of Louisiana at Monroe , Monroe , Louisiana.
  • Siddique AB; a Department of Basic Pharmaceutical Sciences, School of Pharmacy , University of Louisiana at Monroe , Monroe , Louisiana.
  • Kamal AM; a Department of Basic Pharmaceutical Sciences, School of Pharmacy , University of Louisiana at Monroe , Monroe , Louisiana.
  • Haggag EG; b Department of Pharmacognosy, Faculty of Pharmacy , Helwan University , Helwan , Cairo , Egypt.
  • El Sayed KA; b Department of Pharmacognosy, Faculty of Pharmacy , Helwan University , Helwan , Cairo , Egypt.
Nutr Cancer ; 69(8): 1256-1271, 2017.
Article en En | MEDLINE | ID: mdl-29083228
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Rutina / Proteínas Proto-Oncogénicas c-met / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Prognostic_studies Idioma: En Revista: Nutr Cancer Año: 2017 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Rutina / Proteínas Proto-Oncogénicas c-met / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Prognostic_studies Idioma: En Revista: Nutr Cancer Año: 2017 Tipo del documento: Article